KR102259117B1 - 시트 성형체 및 지혈재 - Google Patents

시트 성형체 및 지혈재 Download PDF

Info

Publication number
KR102259117B1
KR102259117B1 KR1020147031716A KR20147031716A KR102259117B1 KR 102259117 B1 KR102259117 B1 KR 102259117B1 KR 1020147031716 A KR1020147031716 A KR 1020147031716A KR 20147031716 A KR20147031716 A KR 20147031716A KR 102259117 B1 KR102259117 B1 KR 102259117B1
Authority
KR
South Korea
Prior art keywords
molded article
fibrinogen
thrombin
polymer
laminated sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147031716A
Other languages
English (en)
Korean (ko)
Other versions
KR20150020536A (ko
Inventor
유카코 가게야마
겐타로 후지나가
아유코 야마구치
유스케 아키야마
아키토시 오오노
스스무 혼다
마코토 사타케
히로아키 가네코
다카유키 이마무라
료이치 가와무라
마사키 히라시마
Original Assignee
데이진 가부시키가이샤
데이진 화-마 가부시키가이샤
케이엠 바이올로직스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이진 가부시키가이샤, 데이진 화-마 가부시키가이샤, 케이엠 바이올로직스 가부시키가이샤 filed Critical 데이진 가부시키가이샤
Publication of KR20150020536A publication Critical patent/KR20150020536A/ko
Application granted granted Critical
Publication of KR102259117B1 publication Critical patent/KR102259117B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
KR1020147031716A 2012-05-14 2013-05-13 시트 성형체 및 지혈재 Active KR102259117B1 (ko)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2012110391 2012-05-14
JP2012110393 2012-05-14
JPJP-P-2012-110391 2012-05-14
JP2012110392 2012-05-14
JPJP-P-2012-110392 2012-05-14
JPJP-P-2012-110394 2012-05-14
JP2012110394 2012-05-14
JPJP-P-2012-110393 2012-05-14
JPJP-P-2013-003273 2013-01-11
JP2013003273 2013-01-11
PCT/JP2013/063872 WO2013172472A1 (ja) 2012-05-14 2013-05-13 シート成形体および止血材

Publications (2)

Publication Number Publication Date
KR20150020536A KR20150020536A (ko) 2015-02-26
KR102259117B1 true KR102259117B1 (ko) 2021-05-31

Family

ID=49583870

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147031716A Active KR102259117B1 (ko) 2012-05-14 2013-05-13 시트 성형체 및 지혈재

Country Status (23)

Country Link
US (2) US10485894B2 (cg-RX-API-DMAC7.html)
EP (1) EP2851095B1 (cg-RX-API-DMAC7.html)
JP (2) JP5844894B2 (cg-RX-API-DMAC7.html)
KR (1) KR102259117B1 (cg-RX-API-DMAC7.html)
CN (1) CN104271164B (cg-RX-API-DMAC7.html)
AR (1) AR091031A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013261312B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014028471B8 (cg-RX-API-DMAC7.html)
CA (1) CA2873162C (cg-RX-API-DMAC7.html)
DK (1) DK2851095T3 (cg-RX-API-DMAC7.html)
ES (1) ES2890098T3 (cg-RX-API-DMAC7.html)
HU (1) HUE056396T2 (cg-RX-API-DMAC7.html)
IL (1) IL235689B (cg-RX-API-DMAC7.html)
MX (1) MX357254B (cg-RX-API-DMAC7.html)
MY (1) MY173719A (cg-RX-API-DMAC7.html)
NZ (1) NZ631084A (cg-RX-API-DMAC7.html)
PH (1) PH12014502535B1 (cg-RX-API-DMAC7.html)
PL (1) PL2851095T3 (cg-RX-API-DMAC7.html)
RU (1) RU2669569C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201407549YA (cg-RX-API-DMAC7.html)
TW (1) TWI584825B (cg-RX-API-DMAC7.html)
WO (1) WO2013172472A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201408258B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013261312B2 (en) * 2012-05-14 2016-11-17 Km Biologics Co., Ltd. Sheet molding and hemostatic material
CA3004272C (en) * 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
CN108883077A (zh) * 2016-03-07 2018-11-23 国立大学法人大阪大学 神经损伤治疗用药剂缓释片材
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
BR112019014236A2 (pt) * 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
KR102029926B1 (ko) * 2017-12-14 2019-10-08 금오공과대학교 산학협력단 풀루란을 이용한 하이드로젤 지혈제 및 그 제조방법
WO2019158734A1 (en) * 2018-02-15 2019-08-22 Biom'up Multi-dimensional hemostatic product and method for producing the same
KR20210143764A (ko) 2019-03-20 2021-11-29 아스텔라스세이야쿠 가부시키가이샤 트롬빈 담지 지혈용 시트
BR112022000513A2 (pt) * 2019-07-12 2022-03-03 Gatt Tech B V Método para preparar uma folha adesiva tecidual e folha adesiva tecidual
AU2020312628B2 (en) 2019-07-12 2025-08-14 Gatt Technologies B.V. Biocompatible, flexible, haemostatic sheet
JP7530182B2 (ja) * 2020-02-06 2024-08-07 株式会社東芝 生体適合部材
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
JP2025504260A (ja) 2021-12-30 2025-02-07 バクスター・インターナショナル・インコーポレイテッド フィブリンシーラント用のフィブリノーゲン溶液及びトロンビン溶液並びにフィブリンシーラントキット
WO2025144087A1 (ru) * 2023-12-24 2025-07-03 Олег ЕВСЕЕНКОВ Гемостатическое средство

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513645A (ja) * 1998-05-07 2002-05-14 ジェンザイム・コーポレーション 止血化合物および生体吸収性ポリマーを含む組成物
JP2006501949A (ja) 2002-10-04 2006-01-19 ナノマトリックス，インコーポレイテッド 皮膚およびその他の組織のためのシーラント
WO2006028244A1 (ja) 2004-09-07 2006-03-16 Teijin Limited 生体吸収性多孔体
WO2007110783A2 (en) * 2006-03-28 2007-10-04 Gustavo Larsen Method of manufacturing fibrous hemostatic bandages
US20090192429A1 (en) 2007-12-06 2009-07-30 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
JP2012087122A (ja) 2010-10-19 2012-05-10 Tyco Healthcare Group Lp 治療剤の送達のための自己支持型フィルム

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
SE439078B (sv) 1984-07-17 1985-05-28 Philips Norden Ab Anordning vid en avstembar magnetron
DE19521324C1 (de) 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
WO1997033633A1 (en) 1996-03-15 1997-09-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue adhesive applied with spray
ATE439150T1 (de) 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
AU755486B2 (en) 1998-05-19 2002-12-12 American National Red Cross, The Hemostatic sandwich bandage
EE05587B1 (et) * 2001-01-25 2012-10-15 Nycomed Pharma As Meetod kollageenk„sna valmistamiseks
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
US20030198659A1 (en) * 2001-10-25 2003-10-23 Hoffmann Michael P. Fibrous pest control
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
WO2004043503A1 (ja) * 2002-11-14 2004-05-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute トロンビン固定化生体吸収性合成不織布
US20060051340A1 (en) 2003-01-20 2006-03-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic materials
TW200424385A (en) 2003-02-13 2004-11-16 Teijin Ltd Porous fiber, porous fiber structure and method for production thereof
EP1731633A4 (en) 2004-03-16 2007-12-19 Teijin Ltd EXTREMELY FINE POLYMILIC ACID FIBER, FIBERS AND METHOD OF MANUFACTURING THEM
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
EP1759718A4 (en) 2004-05-21 2011-03-02 Chemo Sero Therapeut Res Inst PREPARATION OF TISSUE COLLAGE
CA2584698C (en) * 2004-10-20 2014-02-25 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
BRPI0621537B8 (pt) 2006-04-10 2021-05-25 Ethicon Inc curativo hemostático de múltiplas camadas absorvível e reforçado para curativo, e método de fabricação
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
JP5192254B2 (ja) 2008-02-08 2013-05-08 一般財団法人化学及血清療法研究所 シート状組織接着剤
WO2009128474A1 (ja) * 2008-04-16 2009-10-22 財団法人化学及血清療法研究所 トロンビン固定化生体吸収性シート製剤の製造方法
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
JP5675607B2 (ja) 2009-06-11 2015-02-25 一般財団法人化学及血清療法研究所 創傷被覆材
EP2477617B1 (en) * 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
US8329211B2 (en) 2010-05-17 2012-12-11 Ethicon, Inc. Reinforced absorbable multi-layered fabric for hemostatic applications
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
JP5889188B2 (ja) * 2010-07-20 2016-03-22 一般財団法人化学及血清療法研究所 組織接着用シート製剤
CN103999388B (zh) 2011-10-26 2017-10-03 Lg电子株式会社 在无线通信系统中分配控制信道的方法和设备
AU2013261312B2 (en) * 2012-05-14 2016-11-17 Km Biologics Co., Ltd. Sheet molding and hemostatic material
RU2695522C2 (ru) * 2012-05-14 2019-07-23 Тейдзин Лимитед Стерильная композиция

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513645A (ja) * 1998-05-07 2002-05-14 ジェンザイム・コーポレーション 止血化合物および生体吸収性ポリマーを含む組成物
JP2006501949A (ja) 2002-10-04 2006-01-19 ナノマトリックス，インコーポレイテッド 皮膚およびその他の組織のためのシーラント
WO2006028244A1 (ja) 2004-09-07 2006-03-16 Teijin Limited 生体吸収性多孔体
WO2007110783A2 (en) * 2006-03-28 2007-10-04 Gustavo Larsen Method of manufacturing fibrous hemostatic bandages
US20090192429A1 (en) 2007-12-06 2009-07-30 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
JP2012087122A (ja) 2010-10-19 2012-05-10 Tyco Healthcare Group Lp 治療剤の送達のための自己支持型フィルム

Also Published As

Publication number Publication date
ZA201408258B (en) 2015-10-28
HUE056396T2 (hu) 2022-02-28
JP2016073641A (ja) 2016-05-12
HK1204774A1 (en) 2015-12-04
CN104271164B (zh) 2017-11-17
JP5844894B2 (ja) 2016-01-20
BR112014028471A2 (pt) 2018-07-17
JP6277172B2 (ja) 2018-02-07
RU2669569C2 (ru) 2018-10-12
PH12014502535A1 (en) 2015-01-21
AU2013261312B2 (en) 2016-11-17
MX357254B (es) 2018-07-03
BR112014028471B1 (pt) 2020-05-05
EP2851095A1 (en) 2015-03-25
PL2851095T3 (pl) 2022-01-10
JPWO2013172472A1 (ja) 2016-01-12
MX2014013817A (es) 2015-05-11
ES2890098T3 (es) 2022-01-17
RU2014150544A (ru) 2016-07-10
NZ631084A (en) 2016-06-24
TWI584825B (zh) 2017-06-01
CA2873162C (en) 2021-07-27
AR091031A1 (es) 2014-12-30
KR20150020536A (ko) 2015-02-26
IL235689B (en) 2021-10-31
EP2851095A4 (en) 2015-06-17
WO2013172472A1 (ja) 2013-11-21
US11433160B2 (en) 2022-09-06
CN104271164A (zh) 2015-01-07
TW201406410A (zh) 2014-02-16
US20150151020A1 (en) 2015-06-04
US20200046877A1 (en) 2020-02-13
IL235689A0 (en) 2015-01-29
CA2873162A1 (en) 2013-11-21
DK2851095T3 (da) 2021-09-13
AU2013261312A1 (en) 2015-03-05
SG11201407549YA (en) 2014-12-30
PH12014502535B1 (en) 2015-01-21
BR112014028471B8 (pt) 2020-05-26
EP2851095B1 (en) 2021-07-14
MY173719A (en) 2020-02-18
US10485894B2 (en) 2019-11-26

Similar Documents

Publication Publication Date Title
KR102259117B1 (ko) 시트 성형체 및 지혈재
Hassiba et al. Review of recent research on biomedical applications of electrospun polymer nanofibers for improved wound healing
AU2014233480B2 (en) Low molecular weight silk compositions and stabilizing silk compositions
Ali et al. Design, development, in-vitro and in-vivo evaluation of polylactic acid-based multifunctional nanofibrous patches for efficient healing of diabetic wounds
KR102037555B1 (ko) 멸균 조성물
KR101733865B1 (ko) 전기방사형 고분자 섬유를 포함하는 지혈재 및 그 제조방법
RU2678828C2 (ru) Белковая композиция, устойчивая к стерилизации облучением
JP5927061B2 (ja) シート状止血材
EP3981443A1 (en) Improved wound dressings, methods for making these, and uses thereof
JPWO2012029971A1 (ja) フィブリン糊と繊維成形体との複合体
HK1204774B (en) Sheet molding and hemostatic material
JP5479584B2 (ja) 生体糊用補強材及びその製造方法
JP5856785B2 (ja) 止血効果に優れたシート状止血材
Mukherjee et al. Unlocking the potential of engineered biopolymer-based nanofibers for the management of diabetic wounds: a review
WO2012023594A1 (ja) 低帯電性繊維およびその製造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141112

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180509

Comment text: Request for Examination of Application

PN2301 Change of applicant

Patent event date: 20181214

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200110

Patent event code: PE09021S01D

AMND Amendment
E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20200710

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210125

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200710

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20200110

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210125

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200309

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20210317

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20210222

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20210125

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20200309

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210526

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210526

End annual number: 3

Start annual number: 1

PG1601 Publication of registration